Targeted therapy in addition to radiation may be a viable approach to head and neck squamous cell carcinoma, although more research is needed before such treatment becomes part of the standard of care, according to experts interviewed for this article.
Electrical Stimulation to Treat Tinnitus
Early data on stimulation of Heschl’s gyrus are promising, but more research is needed
Improved Fat Grafting Techniques Gain Popularity, Offering Safety and Affordability
Multispecialty Collaboration: Learning from Our Past to Shape Our Future
One of the enjoyable aspects of our specialty is the variety of patients and problems we see every day.
Hemangioma Treatment not One Size Fits All
Balloon Sinuplasty: A Gentler Approach to Opening Blocked Sinuses
A new, minimally invasive technology known as balloon sinuplasty can safely and successfully dilate blocked sinus ostia in select patients with chronic sinusitis, according to early observations in a small number of patients.
Head and Neck Cancer Patients Who Don’t Drink or Smoke Have Worse Outcomes
Patients with head and neck squamous cell carcinoma (HNSCC) who have no history of tobacco or significant alcohol use appear to be more likely to present with earlier disease and smaller initial T-stage, but have worse than expected outcomes.
Prescription Drug Benefit Primer
This January, the Medicare Prescription Drug Benefit, created by the Medicare Prescription Drug, Improvement, and Modernization Act of 2003 (MMA), took effect.
Pills vs. Injections: Which Steroids Are Best for Sudden Hearing Loss?
It is agreed that sudden single-sided deafness is an emergency that is typically treated with corticosteroids.
PET Not Ready for Routine Management of Head and Neck Cancer
The use of positron emission tomography (PET) is not sensitive enough to warrant routine use in post-curative chemoradiation therapy diagnosis of patients with node-positive head and neck cancer, according to researchers in the field.